Overview

A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare anti-inflammatory effects of two anti-fibrinolyntic drugs (Tranexamic acid versus Epsilon-aminocaproic acid) in pediatric patients undergoing pediatric cardiac surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Andrew VanBergen, MD
Treatments:
Aminocaproic Acid
Anti-Inflammatory Agents
Tranexamic Acid